REVA Medical Overview
- Founded
-
1998

- Status
-
Private
- Employees
-
51

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$45M
- Investors
-
5
REVA Medical General Information
Description
Developer of thin-walled heart and coronary artery stents from bioresorbable polymer technologies designed for the treatment of coronary artery disease. The company's lead product is a drug-eluting bioresorbable scaffold made from the company's proprietary tyrosine-derived polymer designed to support the artery through the healing process and then disappear from the body in order to restore natural function to the artery, helping patients to heal from cardiovascular diseases.
Contact Information
Website
www.revamedical.com
Formerly Known As
MD3
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
- 5751 Copley Drive
- San Diego, CA 92111
- United States
+1 (858) 000-0000
REVA Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Later Stage VC (Series B) | 09-Aug-2022 | $45M | 00000 | Completed | Profitable | |
11. 2PO | 24-Apr-2017 | 000.00 | 00000 | Completed | Profitable | |
10. IPO | 23-Dec-2010 | 000.00 | 00000 | 00000 | Completed | Profitable |
9. Later Stage VC (Series H) | 01-Sep-2010 | 0000 | 000.00 | Completed | Profitable | |
8. Secondary Transaction - Private | 01-Mar-2009 | 000.00 | Completed | Generating Revenue | ||
7. Later Stage VC | 16-Nov-2004 | 000.00 | Completed | Generating Revenue | ||
6. Later Stage VC (Series G) | 01-Oct-2004 | 000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC (Series E) | 01-Feb-2002 | 0000 | 000.00 | Completed | Generating Revenue | |
4. Later Stage VC (Series D) | 01-Feb-2001 | $2M | $4.48M | Completed | Generating Revenue | |
3. Later Stage VC (Series C) | 01-Jul-2000 | $1.1M | $2.48M | Completed | Generating Revenue |
REVA Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of thin-walled heart and coronary artery stents from bioresorbable polymer technologies designed for the treat
Other Devices and Supplies
San Diego, CA
51
As of 2017
00000
00000000000
00000
REVA Medical Competitors (17)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ShockWave Medical | Formerly VC-backed | Santa Clara, CA | 000 | 00000 | 000000000 | 00000 |
0000000000000 | Corporation | New York, NY | 000 | 000.00 | 000000 - 000 | 000.00 |
0000000 | Corporation | Danvers, MA | 0000 | 000.00 | 000000&0 | 000.00 |
000000 0000000 | Formerly VC-backed | Audubon, PA | 0000 | 00000 | 000000 - 000 | 00000 |
00000 0000000 | Formerly VC-backed | Irvine, CA | 000 | 00000 | 00000000 | 00000 |
REVA Medical Patents
REVA Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2022501365-A | Porous bioabsorbable radiodensity embolic embolic microspheres for drug delivery | Pending | 20-Sep-2018 | 0000000000 | |
US-20220001073-A1 | Porous bioresorbable radiopaque embolic microspheres for drug delivery | Pending | 20-Sep-2018 | 0000000000 | |
EP-3852731-A1 | Porous bioresorbable radiopaque embolic microspheres for drug delivery | Pending | 20-Sep-2018 | 0000000000 | |
AU-2019342731-A1 | Porous bioresorbable radiopaque embolic microspheres for drug delivery | Pending | 20-Sep-2018 | 0000000000 | |
CA-3110898-A1 | Porous bioresorbable radiopaque embolic microspheres for drug delivery | Pending | 20-Sep-2018 | A61L24/001 |
REVA Medical Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jeffrey Anderson | Chief Executive Officer, President & Board Member | ||
Robert Schultz Ph.D | President | ||
Jessica Earley | Chief Technology Officer |
REVA Medical Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Bernard Lyons Ph.D | Self | Board Member | 000 0000 |
Brian Dovey | Domain Associates | Board of Director, Chairman of Compensation Committee and Member of Nominating and Corporate Governa | 000 0000 |
Jeffrey Anderson | REVA Medical | Chief Executive Officer, President & Board Member | 000 0000 |
Louis Cannon MD | BioStar Capital | Board Member | 000 0000 |
Nick Taylor | Self | Board Member | 000 0000 |
REVA Medical Signals
REVA Medical Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BioStar Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Bain Capital Public Equity | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Domain Associates | Venture Capital | Minority | 000 0000 | 000000 0 | |
Group Outcome | Merchant Banking Firm | Minority | 000 0000 | 000000 0 | |
Saints Capital | Secondary Buyer | Minority | 000 0000 | 000000 0 |